-

Ventas Declares First Quarter 2023 Dividend of $0.45 per Common Share

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on April 13, 2023 to stockholders of record as of the close of business on April 3, 2023.

About Ventas

Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, hospitals and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.

Contacts

BJ Grant
(877) 4-VENTAS

Industry:

Ventas, Inc.

NYSE:VTR
Release Versions
English

Contacts

BJ Grant
(877) 4-VENTAS

More News From Ventas, Inc.

Ventas Announces Pricing of Senior Notes Offering

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that its wholly owned subsidiary, Ventas Realty, Limited Partnership (“Ventas Realty”), has priced an underwritten public offering of $500.0 million aggregate principal amount of 5.000% Senior Notes due 2036 (the “Notes”) at an issue price equal to 99.510% of the principal amount of the Notes. The Notes will be senior unsecured obligations of Ventas Realty and will be fully and unconditionally guarant...

Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research and Chief Executive Officer of Lillibridge Healthcare Services, has informed the Company of his intention to retire on May 1, 2026. Ventas will commence a search process to identify a successor. “Pete has been instrumental in elevating and driving excellence across our Outpatient Medical & Research and Lillibridg...

Ventas Reports 2025 Third Quarter Results

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2025. CEO Remarks “Ventas delivered strong financial performance and growth in the third quarter as we continued to execute on our 1-2-3 strategy. Results in the quarter were powered by our senior housing operating portfolio (SHOP), which experienced broad-based demand and grew organically year-over-year by double digits,” said Debra A. Cafaro, Ventas C...
Back to Newsroom